More answers like this
GPT-5Oct 13, 2026openai/gpt-5-2025-08-07
Should AI development be paused or restricted?
Short answer: Some AI development should be paused or restricted, but a blanket halt on all AI work would do more harm than good. A targeted, risk-based approach is most practical.
When a pause makes sense
•Temporary moratoria on specific, high-risk activities until safeguards exist—for example:
•Training runs above a defined compute/capability threshold.
•Deploying systems that show dangerous dual‑use capabilities (e.g., credible bio or cyber offense) without proven mitigations.
•Clear “restart” conditions: independent safety evaluations passed, red‑team results addressed, incident response plans in place, and post‑deployment monitoring set up.
What to restrict (and how)
•Licensing/registration for frontier training and deployment above thresholds (compute, model size, or measured capabilities).
•Mandatory pre‑deployment risk assessments and third‑party audits, with tiered requirements by risk level.
•Robust red‑teaming focused on bio/cyber, autonomy, deception, and model manipulation.
•Post‑deployment monitoring, incident/accident reporting, and rapid update/rollback mechanisms.
•Access controls for powerful tools/features (sandboxing, rate limits, tool segregation, geofencing).
•Content and behavior safeguards: refuse help for violent, criminal, or self‑harm activities; protect privacy and IP.
•Security-by-design: protect model weights, training data, and tool APIs; adversarial testing; supply‑chain security.
•Traceability: dataset documentation, model/weight lineage, and provenance/watermarking for generated media.
•Transparency to regulators (not necessarily to competitors): compute used, eval results, significant incidents.
•Liability and insurance proportional to foreseeable risks; environmental/energy reporting for very large training runs.
•International coordination on export controls for the most capable chips and high‑risk model weights.
What not to do
•One-size-fits-all freezes on all research or open-source work; this would entrench incumbents and slow beneficial innovation.
•Publishing operationally dangerous, detailed instructions (bio/cyber/chemical) in the name of “openness.”
Constructive alternatives to broad pauses
•Fund and prioritize safety and alignment research, evaluation methods, and red‑team ecosystems.
•Standardize capability and safety benchmarks; require independent replication for key claims.
•Staged release: limited pilots with kill‑switches and strict monitoring before wide availability.
•Societal adaptation: reskilling programs; support for workers in impacted sectors; public procurement of safe, beneficial AI.
Practical path forward
•Adopt a risk‑tiered regime: the higher the potential for systemic harm, the stronger the controls—up to temporary pauses.
•Define measurable thresholds (compute, data, or demonstrated capabilities), not just model size.
•Require independent audits and continuous monitoring for systems in critical domains (health, finance, infrastructure, elections).
•Coordinate internationally on thresholds and reporting so rules can’t be easily arbitraged.
If you share your context (policymaker, company leader, researcher, or voter), I can tailor concrete steps, draft policy language, or an internal governance checklist.